Nuveen Asset Management, LLC Castle Biosciences Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 542,593 shares of CSTL stock, worth $15.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

542,593

Previous 286,511 89.38%

Holding current value

$15.3 Million

Previous $6.24 Million 148.1%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.4 - $31.47 $4.46 Million - $8.06 Million	256,082 Added 89.38%	542,593 $15.5 Million
Q2 2024 Aug 09, 2024	BUY	$18.84 - $24.94 $1.83 Million - $2.42 Million	96,883 Added 51.09%	286,511 $6.24 Million
Q1 2024 May 13, 2024	BUY	$18.06 - $25.3 $129,201 - $180,996	7,154 Added 3.92%	189,628 $4.2 Million
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $75,456 - $138,841	6,190 Added 3.51%	182,474 $3.94 Million
Q3 2023 Nov 14, 2023	SELL	$13.28 - $20.3 $3.19 Million - $4.87 Million	-240,130 Reduced 57.67%	176,284 $2.98 Million
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $124,248 - $277,056	10,656 Added 2.63%	416,414 $5.71 Million
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $2.01 Million - $2.94 Million	103,109 Added 34.07%	405,758 $9.22 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $3.47 Million - $5.76 Million	191,974 Added 173.46%	302,649 $7.12 Million
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $44,569 - $67,953	-1,980 Reduced 1.76%	110,675 $2.89 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $654,208 - $1.88 Million	40,888 Added 56.97%	112,655 $2.47 Million
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $25,739 - $36,456	776 Added 1.09%	71,767 $3.13 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $215,650 - $373,109	-5,521 Reduced 7.22%	70,991 $2.76 Million
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $329,151 - $424,782	-5,474 Reduced 6.68%	76,512 $5.92 Million
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $1.52 Million - $2.33 Million	30,342 Added 58.75%	81,986 $6.01 Million
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $1.72 Million - $2.84 Million	-29,149 Reduced 36.08%	51,644 $3.54 Million
Q4 2020 Feb 16, 2021	SELL	$43.6 - $73.05 $152,992 - $256,332	-3,509 Reduced 4.16%	80,793 $5.43 Million
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $1.13 Million - $1.53 Million	29,462 Added 53.72%	84,302 $4.34 Million
Q2 2020 Aug 14, 2020	SELL	$27.28 - $43.01 $262,570 - $413,971	-9,625 Reduced 14.93%	54,840 $2.07 Million
Q1 2020 May 14, 2020	SELL	$23.08 - $35.53 $1.16 Million - $1.79 Million	-50,272 Reduced 43.81%	64,465 $1.92 Million
Q4 2019 Feb 14, 2020	SELL	$15.74 - $35.04 $795,956 - $1.77 Million	-50,569 Reduced 30.59%	114,737 $3.94 Million
Q3 2019 Nov 14, 2019	BUY	$18.09 - $27.92 $2.99 Million - $4.62 Million	165,306 New	165,306 $2.99 Million

Others Institutions Holding CSTL

# of Institutions

202

Shares Held

26M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $740M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Castle Biosciences Inc Transaction History